AI Drug Discovery Hits a Lab Bottleneck, Sparking a New Market

AI tools now design drug candidates faster than labs can test them. 10x Science, a Y Combinator-backed startup, raised $4.8M to close this gap with AI-powered protein testing tools. The mismatch between what computation produces and what labs can verify points to new business opportunities beyond full-stack discovery platforms. **Analysis:** This mirrors past cycles where new tools outpaced the infrastructure needed to use them.